HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers... Show more
HIVE Digital Technologies has evolved from a pure Bitcoin miner into a "dual-engine" infrastructure operator that pairs digital-asset mining with accelerated AI computing through its wholly owned BUZZ HPC unit. That hybrid structure is a structural differentiator: the company monetizes the same energy and data-center assets across two demand cycles, reducing its reliance on any single revenue stream.
A key competitive advantage is its clean-energy footprint across Canada, Sweden, and Paraguay, combined with years of operating at scale around uptime and energy efficiency. Management argues this track record is precisely what enterprise AI customers evaluate when renting dedicated GPU capacity. The company has converted that positioning into multi-year contracts with investment-grade and sovereign AI counterparties, including a three-year agreement with AI developer Cohere.
The medium-term strategy is capital reallocation rather than outright exit from mining. HIVE is winding down lower-value Swedish mining while directing power toward HPC workloads and planning a 320-megawatt AI facility in the Greater Toronto Area capable of hosting over 100,000 GPUs. Structural risks include financing costs, customer concentration among a handful of large contracts, and the rapid obsolescence cycle of GPU hardware.
The clearest near-term catalyst is the November 16, 2026 earnings release, which will show whether HIVE converts contracted AI revenue into realized results and how effectively it funds its GPU expansion. Investors will also track the deployment of 2,016 NVIDIA Blackwell Ultra GPUs expected to become operational in late 2026, a rollout management has tied to a target of roughly $500,000 in daily HPC and AI revenue.
Analyst actions have been broadly constructive but not uniform. Consensus coverage sits at a Strong Buy, with an average price target near $6.83 to $6.95 and a high of $10 from Canaccord Genuity. Recent revisions have tilted higher, including raises from Rosenblatt, B. Riley, and Cantor Fitzgerald, alongside new coverage initiated with a Buy by Chardan Capital. At the same time, KBW (Keefe, Bruyette & Woods) has maintained a Hold rating and recently lowered its target to $2.50, underscoring a mixed element in the ratings profile and reflecting caution around execution and financing risk.
Beyond earnings, the timing of GPU deliveries, the pace of converting the company's roughly $1 billion pipeline into signed contracts, and any progress on sovereign AI mandates will shape investor sentiment into 2026 and 2027.
HIVE sits at the intersection of two macro-sensitive sectors. Bitcoin mining revenue is tied to digital-asset prices, network difficulty, and energy costs, all of which fluctuate with liquidity conditions and risk appetite. Elevated interest rates raise the cost of the debt used to finance GPU purchases, making the company's recently secured 9% fixed-rate, GPU-backed loan a direct measure of that sensitivity.
The AI side of the business benefits from a structural tailwind: persistent scarcity of power-connected, GPU-ready data-center capacity amid surging demand for AI training and inference. Sovereign AI initiatives, particularly Canada's push to keep compute capacity domestic, are a favorable policy backdrop. Counterbalancing forces include intensifying competition from hyperscalers and other miners pivoting into HPC, supply-chain constraints on advanced chips, and growing regulatory scrutiny of data-center energy consumption.
For traders seeking a data-driven read on HIVE and similar assets, Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps identify whether a stock, ETF (exchange-traded fund), or other asset may move bullish, bearish, or sideways over the coming week or month. The engine is designed to help users spot developing trends, evaluate potential breakouts or reversals, and explore predictions across a broad range of tradable instruments. It includes searchable prediction categories, historical context, and alert-oriented functionality to keep traders informed as conditions evolve. Explore the Trend Prediction Engine to see how algorithmic signals can complement your own research.
Looking toward 2026 and beyond, HIVE's trajectory hinges on how successfully it scales recurring AI revenue while managing the capital intensity of that buildout. The company's stated ambition of becoming a leading Canadian hyperscaler implies a meaningful shift in margin structure, from volatile mining economics toward contracted, higher-visibility cash flows. Sustainability of those margins will depend on utilization rates, hardware refresh cycles, and the durability of customer demand.
Key long-term themes include the expansion of sovereign AI infrastructure, the continued repurposing of legacy mining power toward HPC, and the evolution of financing markets that now lend against GPUs rather than depreciating mining rigs. Competitive threats from larger hyperscalers and peer miners are real, and regulatory developments around data-center energy use could raise operating costs. Consensus analyst expectations remain optimistic, but the gap between a sub-$2 stock price and an average price target above $6 reflects the market's pricing of meaningful execution risk. Whether HIVE closes that gap will depend less on Bitcoin's next move and more on its ability to convert contracted AI commitments into profitable, recurring operations.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HIVE has been closely correlated with CLSK. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIVE jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To HIVE | 1D Price Change % | ||
|---|---|---|---|---|
| HIVE | 100% | -14.44% | ||
| CLSK - HIVE | 76% Closely correlated | -16.27% | ||
| KEEL - HIVE | 76% Closely correlated | -19.33% | ||
| BTBT - HIVE | 75% Closely correlated | -13.68% | ||
| CIFR - HIVE | 73% Closely correlated | -16.13% | ||
| COIN - HIVE | 73% Closely correlated | -6.34% | ||
More | ||||
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers
The Aroon Indicator for HIVE entered a downward trend on November 20, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 333 similar instances where the Aroon Indicator formed such a pattern. In 301 of the 333 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 31 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 210 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
HIVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.143). P/E Ratio (9.174) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.975) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (17.075).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.